(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|
Turnover | 120.97%727.09M | --360.97M | 111.22%1.12B | 38.70%329.05M | 60.19%530.32M | --237.24M | 93.68%331.06M | --170.93M |
Operating income | 120.97%727.09M | 360.97M | 111.22%1.12B | 38.70%329.05M | 60.19%530.32M | 237.24M | 93.68%331.06M | 170.93M |
Cost of sales | -98.72%-628.54M | ---316.49M | -80.21%-1.03B | -54.95%-316.3M | -198.55%-569.62M | ---204.13M | -99.66%-190.8M | ---95.56M |
Operating expenses | -98.72%-628.54M | -316.49M | -80.21%-1.03B | -54.95%-316.3M | -198.55%-569.62M | -204.13M | -99.66%-190.8M | -95.56M |
Gross profit | 672.84%98.55M | 44.48M | 338.30%93.64M | -61.49%12.75M | -128.01%-39.3M | 33.11M | 86.11%140.27M | 75.37M |
Selling expenses | -41.95%-57.03M | ---28.4M | -27.65%-86.01M | -36.56%-40.17M | -43.70%-67.38M | ---29.42M | -98.58%-46.89M | ---23.61M |
Administrative expenses | 51.77%-82.25M | ---38.29M | -83.67%-345.94M | -110.64%-170.52M | -32.29%-188.35M | ---80.95M | -278.62%-142.37M | ---37.6M |
Research and development expenses | -27.18%-313.35M | ---148.56M | -107.59%-635.11M | -135.13%-246.39M | -129.97%-305.94M | ---104.79M | -63.17%-133.04M | ---81.53M |
Impairment and provision | 666.48%1.03M | --1.42M | 8.55%-2.29M | 91.34%-182K | 13.25%-2.5M | ---2.1M | -66.51%-2.88M | ---1.73M |
-Other impairment is provision | 666.48%1.03M | --1.42M | 8.55%-2.29M | 91.34%-182K | 13.25%-2.5M | ---2.1M | -66.51%-2.88M | ---1.73M |
Special items of operating profit | 282.41%30.97M | --10.15M | 378.05%35.13M | 13.84%-16.98M | -165.31%-12.64M | ---19.71M | 127.56%19.35M | --8.5M |
Operating profit | 30.21%-322.07M | -159.19M | -52.67%-940.58M | -126.38%-461.49M | -272.11%-616.11M | -203.86M | -173.17%-165.57M | -60.61M |
Financing income | 51.83%55.66M | --28.17M | 295.06%80.95M | 1,058.57%36.66M | 1,156.35%20.49M | --3.16M | 8.66%1.63M | --1.5M |
Financing cost | 14.34%-1.61M | ---- | 43.22%-2.87M | 45.83%-1.88M | -97.19%-5.05M | ---3.48M | -210.56%-2.56M | ---824K |
Share of profits of associates | 614.12%4.84M | --3.17M | --4.46M | ---942K | ---- | ---- | ---- | ---- |
Special items of earning before tax | 99.18%-2.8M | ---2.8M | -133.80%-3.47B | 18.08%-339.76M | 0.21%-1.48B | ---414.76M | -826.01%-1.49B | ---160.67M |
Earning before tax | 65.34%-265.98M | -130.64M | -107.60%-4.33B | -23.99%-767.42M | -26.05%-2.09B | -618.93M | -649.90%-1.65B | -220.6M |
Tax | -77.60%-1.54M | ---27K | -132.75%-1.87M | -1,296.77%-866K | -238.82%-803K | ---62K | ---237K | ---- |
After-tax profit from continuing operations | 65.18%-267.52M | -130.67M | -107.61%-4.33B | -24.12%-768.29M | -26.09%-2.09B | -618.99M | -650.01%-1.65B | -220.6M |
Earning after tax | 65.18%-267.52M | -130.67M | -107.61%-4.33B | -24.12%-768.29M | -26.09%-2.09B | -618.99M | -650.01%-1.65B | -220.6M |
Minority profit | -44.44%1.63M | --1.12M | 123.04%5.66M | 58,780.00%2.93M | -39.61%2.54M | ---5K | 2,078.24%4.2M | --193K |
Profit attributable to shareholders | 65.10%-269.15M | -131.79M | -107.63%-4.34B | -24.59%-771.22M | -25.92%-2.09B | -618.99M | -651.26%-1.66B | -220.79M |
Basic earnings per share | 92.19%-0.62 | -0.31 | -108.06%-44.67 | -25.04%-7.94 | -30.36%-21.47 | -6.35 | -655.50%-16.47 | -2.18 |
Diluted earnings per share | 92.19%-0.62 | -0.31 | -108.06%-44.67 | -25.04%-7.94 | -30.36%-21.47 | -6.35 | -655.50%-16.47 | -2.18 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data